The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Distribution vessel Aotearoa Chief in dock at Northport for repairs.
Brent King asked whether it was worth listing on the NZX, a 'government-sanctioned monopoly’.
Long-time Mainfreight director receives thumbs down from some shareholders over $120,000 payment.
Lines company announces conditional sale of LPG business for $150m.
Novitas, the US Medicare Administrative Contractor, delays making final decision on removing Cxbladder from its approved test list.
AGM hears further frustration on cancelled ferry project, while revenue rises in the first 15 weeks of the year.
Drew Davies has resigned from the company with ‘immediate effect’, weeks after the company rebuffed a takeover offer.
The dual-listed Central Otago gold mining company’s stock jumped 3.4% in early NZX trading.
Complaint, seen by NBR, lays out surge in trading activity ahead of announcement Sir Stephen Tindall and PE firm were teaming up on acquisition.